Literature DB >> 27294414

Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.

Ariane Fraiche1, Andrew Wang2.   

Abstract

Since publication of the 2011 American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy (HCM), more recent studies offer greater insights about this condition. With increased recognition of the role of sarcomere protein mutations and myocardial structural abnormalities in the pathophysiology of this disease, new evidence offers potential improvements for the management of patients with HCM. In this review of studies published since 2011, we highlight several studies that may impact diagnostic considerations, risk stratification, and treatment of symptoms in HCM.

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Hypertrophic cardiomyopathy; Risk stratification; Sudden cardiac death; Treatment

Mesh：

Year:  2016        PMID： 27294414     DOI： 10.1007/s11886-016-0751-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  35 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial.

Authors:  Iacopo Olivotto; Jennifer L Hellawell; Ramin Farzaneh-Far; Christiana Blair; Raffaele Coppini; Jonathan Myers; Luiz Belardinelli; Martin S Maron
Journal:  Circ Heart Fail       Date:  2016-03       Impact factor: 8.790

3.  Effects of septal myectomy on left ventricular diastolic function and left atrial volume in patients with hypertrophic cardiomyopathy.

Authors:  Albree Tower-Rader; Nicholas Furiasse; Jyothy J Puthumana; Jane Kruse; Zhi Li; Adin-Cristian Andrei; Vera Rigolin; Robert O Bonow; Patrick M McCarthy; Lubna Choudhury
Journal:  Am J Cardiol       Date:  2014-08-27       Impact factor: 2.778

Review 4.  MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.

Authors:  Jan Bogaert; Iacopo Olivotto
Journal:  Radiology       Date:  2014-11       Impact factor: 11.105

5.  Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.

Authors:  Raffaele Coppini; Cecilia Ferrantini; Lina Yao; Peidong Fan; Martina Del Lungo; Francesca Stillitano; Laura Sartiani; Benedetta Tosi; Silvia Suffredini; Chiara Tesi; Magdi Yacoub; Iacopo Olivotto; Luiz Belardinelli; Corrado Poggesi; Elisabetta Cerbai; Alessandro Mugelli
Journal:  Circulation       Date:  2012-12-27       Impact factor: 29.690

6.  T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Authors:  Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 7.792

7.  Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy.

Authors:  Pieter A Vriesendorp; Arend F L Schinkel; Osama I I Soliman; Marcel J M Kofflard; Peter L de Jong; Lex A van Herwerden; Folkert J Ten Cate; Michelle Michels
Journal:  Am J Cardiol       Date:  2014-12-18       Impact factor: 2.778

8.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

9.  Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Authors:  Paul Sorajja; Steve R Ommen; David R Holmes; Joseph A Dearani; Charanjit S Rihal; Bernard J Gersh; Ryan J Lennon; Rick A Nishimura
Journal:  Circulation       Date:  2012-10-17       Impact factor: 29.690

10.  Native T1 mapping in transthyretin amyloidosis.

Authors:  Marianna Fontana; Sanjay M Banypersad; Thomas A Treibel; Viviana Maestrini; Daniel M Sado; Steven K White; Silvia Pica; Silvia Castelletti; Stefan K Piechnik; Matthew D Robson; Janet A Gilbertson; Dorota Rowczenio; David F Hutt; Helen J Lachmann; Ashutosh D Wechalekar; Carol J Whelan; Julian D Gillmore; Philip N Hawkins; James C Moon
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08
View more
  5 in total

1.  Left ventricular energy loss and wall shear stress assessed by vector flow mapping in patients with hypertrophic cardiomyopathy.

Authors:  Ling Ji; Wenzhi Hu; Yonghong Yong; Hongping Wu; Lei Zhou; Di Xu
Journal:  Int J Cardiovasc Imaging       Date:  2018-04-06       Impact factor: 2.357

Review 2.  Risk stratification in hypertrophic cardiomyopathy.

Authors:  S Marrakchi; I Kammoun; E Bennour; L Laroussi; S Kachboura
Journal:  Herz       Date:  2018-04-25       Impact factor: 1.443

3.  Changes of serum P62 and Beclin 1 in patients with pulmonary embolism during treatment and their predictive value for efficacy.

Authors:  Xuehui Zhang; Liu Huang; Lijiang Shao; Xuxia Chen; Jinguo Chu; Xueqin Chen
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 4.  Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging.

Authors:  Takeshi Kitai; Andrew Xanthopoulos; Shoko Nakagawa; Natsuko Ishii; Masashi Amano; Filippos Triposkiadis; Chisato Izumi
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-25

5.  Heat shock proteins and small nucleolar RNAs are dysregulated in a Drosophila model for feline hypertrophic cardiomyopathy.

Authors:  Christian A Tallo; Laura H Duncan; Akihiko H Yamamoto; Joshua D Slaydon; Gunjan H Arya; Lavanya Turlapati; Trudy F C Mackay; Mary A Carbone
Journal:  G3 (Bethesda)       Date:  2021-01-18       Impact factor: 3.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.